UKVIA Wrote to PM Rishi Sunak, Requesting Reconsideration of the Ban

Regulations by 2FIRSTS.ai
Jan.31.2024
UKVIA Wrote to PM Rishi Sunak, Requesting Reconsideration of the Ban
UK Vaping Industry Association responds to government's disposable e-cigarette ban; urges reconsideration for health reasons.

The official website of the UK Vaping Industry Association responded on January 30 to the government's ban on disposable e-cigarettes and other measures. The association wrote a letter to UK Prime Minister Rishi Sunak expressing their "disappointment and concerns" regarding the government's decision to continue implementing a ban on disposable e-cigarettes.

 

Here's the orginal text on UKVIA's official website:

 

The UKVIA is dismayed at the government’s decision to ban disposable vapes, which have been instrumental in bringing the UK’s smoking rates down to a record low and have played a key role in helping millions of adults quit and stay off cigarettes.

 

While action to prevent youth access to vaping is critical, this move smacks more of a desperate attempt by the government to sacrifice vapers for votes ahead of the upcoming General Election. If the government thinks banning disposables will help protect young people, they are completely misguided. This counterproductive legislation will sooner put children at greater risk by turbo-charging the black market and, in turn, making it easier for them to access illicit and non-compliant vapes.

 

The answer to youth vaping doesn’t lie in counterproductive bans and restrictions, but rather in effective and proactive enforcement – which is woefully lacking – of the law which states that it is illegal for vapes to be sold to minors.  It’s why the UKVIA has been part of a major industry-wide consultation over the last couple of months that has led to the development of a vape retailer and distributor licensing scheme to make it harder for the rogue traders to get away with underage and illicit sales. This is being presented to parliamentarians in February and will raise £50m or more to put towards Trading Standards to increase enforcement without any cost to the taxpayer.

 

In the meantime, we will hold the Government to account for the increased smoking rates, as well as the lives and jobs that will be lost, as a result of their shocking and ill thought through decision today.

 

The announcement comes on the back of new research from University College London, released just last week, which found such a move could discourage the use of vaping as a stop smoking tool and trigger relapse amongst those who have already used disposables to quit, negatively impacting almost two million former and current smokers and setting back the nation’s smokefree 2030 ambitions significantly.

 

It also hands the regulated vaping market to criminals on a silver platter. It is estimated that in Australia, where vapes are now only available on difficult to obtain prescriptions, as many as 92% of vapers are buying their products through illegal channels and as many as 100 million illicit products are smuggled into the country every year. The leading public health charity Action on Smoking and Health UK has previously warned that children already ‘find it easy’ to access illegal vapes as those selling them have ‘no qualms’ selling to minors.

 

Removing disposables will also have huge economic repercussions and significantly impact the financial burden on the NHS, which foots a bill of some £2.4 billion per year currently to treat and care for those with smoking conditions.

 

The UKVIA has long called for greater restrictions around flavour names and descriptors and agrees that products and packaging should not feature youth appealing imagery and language, however, a move to plain packaging conflates them with cigarettes and further deters adult smokers from making the switch.

 

The government must tread extremely carefully when it comes to flavour restrictions. A recent survey conducted by One Poll found that as many as 1.5 million vapers fear they would return to smoking if flavours were banned and 83 percent of vapers claim that flavours have helped them ‘pack in their smoking habit’.

 

In its submission to the recent vaping consultation issued by the Government which has led to the decision to ban disposables, the Royal College of Physicians called for the use of a range of flavours, including fruit flavours to enable smoking cessation in adults, stating: “The use of flavours by adults trying to quit smoking is an integral part of the effectiveness of vaping as a quit aid. Government should restrict flavour descriptors rather than flavours themselves.”

 

NOTE TO EDITORS

 

Content used from this statement can be attributed to John Dunne, Director General of the UK Vaping Industry Association (UKVIA)

 

For further information, contact: 

Chris Lawrance – 07747693905

Robin O’Kelly – 07786 702 526

 

ENDS

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang Industrial Co., Ltd. has filed a patent application for an oral nicotine delivery product designed to let users actively adjust nicotine release. The product embeds two types of nicotine reservoirs with different wall thicknesses and positions inside a deformable matrix. Pressure applied with the tongue or lips can rupture the reservoirs and accelerate nicotine release. In simulated oral tests, several patent examples showed sharply higher peak nicotine release rates as applied force increased from 0 N to 1 N and 3 N. The filing explores a shift from preset release profiles toward user-triggered nicotine delivery.
Sep.01
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
Product | JTI Launches Ploom AURA Teal Electric Pop in South Korea, Its First Dual-Color Edition
Product | JTI Launches Ploom AURA Teal Electric Pop in South Korea, Its First Dual-Color Edition
JTI Korea launched the Ploom AURA Teal Electric Pop limited edition in South Korea on September 1, 2026, marking the first dual-color design in the Ploom AURA range. The device combines a dark green body with teal accents and is accompanied by matching Front Panel, Back Cover and Pocket Bag accessories. The standalone device is priced at KRW 29,000, with three additional device-and-accessory bundles available. The release continues JTI Korea's use of limited colorways and interchangeable accessories to expand the Ploom AURA portfolio without introducing a new hardware platform.
Sep.03
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
Multiple JTI-backed studies in the UK and Ireland indicate that illicit tobacco remains visible across consumer interactions and local markets. In the UK, JTI research found that 31% of respondents said they had been offered illicit tobacco products. In Ireland’s Ennis area, a JTI-commissioned empty pack survey found that 63% of sampled cigarette packs did not carry Irish duty-paid markings. The findings come from industry research rather than official government estimates of illicit tobacco market size, but highlight continued concerns among regulators, legitimate retailers and tobacco companies over illicit trade.
Aug.19